nodes	percent_of_prediction	percent_of_DWPC	metapath
Perhexiline—CYP2B6—Tretinoin—peripheral nervous system neoplasm	0.222	0.351	CbGbCtD
Perhexiline—CYP2B6—Cisplatin—peripheral nervous system neoplasm	0.0949	0.15	CbGbCtD
Perhexiline—CYP3A4—Topotecan—peripheral nervous system neoplasm	0.0732	0.116	CbGbCtD
Perhexiline—CYP3A4—Tretinoin—peripheral nervous system neoplasm	0.0681	0.108	CbGbCtD
Perhexiline—CYP2B6—Doxorubicin—peripheral nervous system neoplasm	0.0636	0.101	CbGbCtD
Perhexiline—CYP3A4—Vincristine—peripheral nervous system neoplasm	0.0313	0.0495	CbGbCtD
Perhexiline—CYP2D6—Doxorubicin—peripheral nervous system neoplasm	0.0307	0.0486	CbGbCtD
Perhexiline—CYP3A4—Etoposide—peripheral nervous system neoplasm	0.0286	0.0453	CbGbCtD
Perhexiline—CYP3A4—Doxorubicin—peripheral nervous system neoplasm	0.0195	0.0309	CbGbCtD
Perhexiline—Hepatocellular injury—Cisplatin—peripheral nervous system neoplasm	0.00219	0.006	CcSEcCtD
Perhexiline—Weight decreased—Tretinoin—peripheral nervous system neoplasm	0.00193	0.00528	CcSEcCtD
Perhexiline—Weight decreased—Isotretinoin—peripheral nervous system neoplasm	0.00193	0.00528	CcSEcCtD
Perhexiline—Neuropathy peripheral—Topotecan—peripheral nervous system neoplasm	0.00188	0.00514	CcSEcCtD
Perhexiline—Neuropathy peripheral—Tretinoin—peripheral nervous system neoplasm	0.00186	0.0051	CcSEcCtD
Perhexiline—Neuropathy peripheral—Isotretinoin—peripheral nervous system neoplasm	0.00186	0.0051	CcSEcCtD
Perhexiline—Neuropathy peripheral—Melphalan—peripheral nervous system neoplasm	0.00184	0.00503	CcSEcCtD
Perhexiline—Sweating—Topotecan—peripheral nervous system neoplasm	0.00183	0.00503	CcSEcCtD
Perhexiline—Optic neuritis—Epirubicin—peripheral nervous system neoplasm	0.00183	0.00501	CcSEcCtD
Perhexiline—Sweating—Tretinoin—peripheral nervous system neoplasm	0.00182	0.00499	CcSEcCtD
Perhexiline—Sweating—Isotretinoin—peripheral nervous system neoplasm	0.00182	0.00499	CcSEcCtD
Perhexiline—Hepatitis—Tretinoin—peripheral nervous system neoplasm	0.0017	0.00467	CcSEcCtD
Perhexiline—Hepatitis—Isotretinoin—peripheral nervous system neoplasm	0.0017	0.00467	CcSEcCtD
Perhexiline—Optic neuritis—Doxorubicin—peripheral nervous system neoplasm	0.00169	0.00464	CcSEcCtD
Perhexiline—Ataxia—Vincristine—peripheral nervous system neoplasm	0.00169	0.00463	CcSEcCtD
Perhexiline—Hepatitis—Melphalan—peripheral nervous system neoplasm	0.00168	0.00461	CcSEcCtD
Perhexiline—Muscular weakness—Vincristine—peripheral nervous system neoplasm	0.00159	0.00435	CcSEcCtD
Perhexiline—Flushing—Tretinoin—peripheral nervous system neoplasm	0.00158	0.00433	CcSEcCtD
Perhexiline—Flushing—Isotretinoin—peripheral nervous system neoplasm	0.00158	0.00433	CcSEcCtD
Perhexiline—Flushing—Melphalan—peripheral nervous system neoplasm	0.00156	0.00428	CcSEcCtD
Perhexiline—Weight decreased—Alitretinoin—peripheral nervous system neoplasm	0.00146	0.004	CcSEcCtD
Perhexiline—Tension—Tretinoin—peripheral nervous system neoplasm	0.00146	0.00399	CcSEcCtD
Perhexiline—Tension—Isotretinoin—peripheral nervous system neoplasm	0.00146	0.00399	CcSEcCtD
Perhexiline—Nervousness—Tretinoin—peripheral nervous system neoplasm	0.00144	0.00395	CcSEcCtD
Perhexiline—Nervousness—Isotretinoin—peripheral nervous system neoplasm	0.00144	0.00395	CcSEcCtD
Perhexiline—Neuropathy peripheral—Alitretinoin—peripheral nervous system neoplasm	0.00141	0.00386	CcSEcCtD
Perhexiline—Weight decreased—Vincristine—peripheral nervous system neoplasm	0.00141	0.00385	CcSEcCtD
Perhexiline—Hepatitis—Dactinomycin—peripheral nervous system neoplasm	0.00139	0.00382	CcSEcCtD
Perhexiline—Tremor—Isotretinoin—peripheral nervous system neoplasm	0.00139	0.00381	CcSEcCtD
Perhexiline—Tremor—Tretinoin—peripheral nervous system neoplasm	0.00139	0.00381	CcSEcCtD
Perhexiline—Sweating—Alitretinoin—peripheral nervous system neoplasm	0.00138	0.00378	CcSEcCtD
Perhexiline—Neuropathy peripheral—Vincristine—peripheral nervous system neoplasm	0.00136	0.00372	CcSEcCtD
Perhexiline—Liver injury—Epirubicin—peripheral nervous system neoplasm	0.00134	0.00366	CcSEcCtD
Perhexiline—Syncope—Tretinoin—peripheral nervous system neoplasm	0.00133	0.00364	CcSEcCtD
Perhexiline—Syncope—Isotretinoin—peripheral nervous system neoplasm	0.00133	0.00364	CcSEcCtD
Perhexiline—Sweating—Vincristine—peripheral nervous system neoplasm	0.00133	0.00364	CcSEcCtD
Perhexiline—Loss of consciousness—Tretinoin—peripheral nervous system neoplasm	0.0013	0.00357	CcSEcCtD
Perhexiline—Loss of consciousness—Isotretinoin—peripheral nervous system neoplasm	0.0013	0.00357	CcSEcCtD
Perhexiline—Flushing—Dactinomycin—peripheral nervous system neoplasm	0.00129	0.00354	CcSEcCtD
Perhexiline—Hepatitis—Alitretinoin—peripheral nervous system neoplasm	0.00129	0.00354	CcSEcCtD
Perhexiline—Convulsion—Isotretinoin—peripheral nervous system neoplasm	0.00129	0.00352	CcSEcCtD
Perhexiline—Convulsion—Tretinoin—peripheral nervous system neoplasm	0.00129	0.00352	CcSEcCtD
Perhexiline—Convulsion—Melphalan—peripheral nervous system neoplasm	0.00127	0.00348	CcSEcCtD
Perhexiline—Liver injury—Doxorubicin—peripheral nervous system neoplasm	0.00124	0.00339	CcSEcCtD
Perhexiline—Neuropathy peripheral—Cisplatin—peripheral nervous system neoplasm	0.0012	0.00329	CcSEcCtD
Perhexiline—Flushing—Alitretinoin—peripheral nervous system neoplasm	0.0012	0.00328	CcSEcCtD
Perhexiline—Shock—Isotretinoin—peripheral nervous system neoplasm	0.00119	0.00326	CcSEcCtD
Perhexiline—Shock—Tretinoin—peripheral nervous system neoplasm	0.00119	0.00326	CcSEcCtD
Perhexiline—Hyperhidrosis—Topotecan—peripheral nervous system neoplasm	0.00118	0.00323	CcSEcCtD
Perhexiline—Hyperhidrosis—Isotretinoin—peripheral nervous system neoplasm	0.00117	0.00321	CcSEcCtD
Perhexiline—Hyperhidrosis—Tretinoin—peripheral nervous system neoplasm	0.00117	0.00321	CcSEcCtD
Perhexiline—Anorexia—Topotecan—peripheral nervous system neoplasm	0.00116	0.00319	CcSEcCtD
Perhexiline—Anorexia—Isotretinoin—peripheral nervous system neoplasm	0.00115	0.00316	CcSEcCtD
Perhexiline—Anorexia—Tretinoin—peripheral nervous system neoplasm	0.00115	0.00316	CcSEcCtD
Perhexiline—Gait disturbance—Epirubicin—peripheral nervous system neoplasm	0.00115	0.00316	CcSEcCtD
Perhexiline—Anorexia—Melphalan—peripheral nervous system neoplasm	0.00114	0.00312	CcSEcCtD
Perhexiline—Hepatocellular injury—Epirubicin—peripheral nervous system neoplasm	0.00113	0.00308	CcSEcCtD
Perhexiline—Tension—Alitretinoin—peripheral nervous system neoplasm	0.0011	0.00302	CcSEcCtD
Perhexiline—Neuropathy peripheral—Etoposide—peripheral nervous system neoplasm	0.0011	0.00302	CcSEcCtD
Perhexiline—Paraesthesia—Topotecan—peripheral nervous system neoplasm	0.0011	0.003	CcSEcCtD
Perhexiline—Insomnia—Tretinoin—peripheral nervous system neoplasm	0.0011	0.003	CcSEcCtD
Perhexiline—Insomnia—Isotretinoin—peripheral nervous system neoplasm	0.0011	0.003	CcSEcCtD
Perhexiline—Nervousness—Alitretinoin—peripheral nervous system neoplasm	0.00109	0.00299	CcSEcCtD
Perhexiline—Paraesthesia—Isotretinoin—peripheral nervous system neoplasm	0.00109	0.00298	CcSEcCtD
Perhexiline—Paraesthesia—Tretinoin—peripheral nervous system neoplasm	0.00109	0.00298	CcSEcCtD
Perhexiline—Paraesthesia—Melphalan—peripheral nervous system neoplasm	0.00107	0.00294	CcSEcCtD
Perhexiline—Gait disturbance—Doxorubicin—peripheral nervous system neoplasm	0.00107	0.00292	CcSEcCtD
Perhexiline—Decreased appetite—Topotecan—peripheral nervous system neoplasm	0.00106	0.00291	CcSEcCtD
Perhexiline—Tremor—Alitretinoin—peripheral nervous system neoplasm	0.00105	0.00289	CcSEcCtD
Perhexiline—Decreased appetite—Isotretinoin—peripheral nervous system neoplasm	0.00105	0.00288	CcSEcCtD
Perhexiline—Decreased appetite—Tretinoin—peripheral nervous system neoplasm	0.00105	0.00288	CcSEcCtD
Perhexiline—Fatigue—Topotecan—peripheral nervous system neoplasm	0.00105	0.00288	CcSEcCtD
Perhexiline—Fatigue—Isotretinoin—peripheral nervous system neoplasm	0.00104	0.00286	CcSEcCtD
Perhexiline—Fatigue—Tretinoin—peripheral nervous system neoplasm	0.00104	0.00286	CcSEcCtD
Perhexiline—Hepatocellular injury—Doxorubicin—peripheral nervous system neoplasm	0.00104	0.00285	CcSEcCtD
Perhexiline—Decreased appetite—Melphalan—peripheral nervous system neoplasm	0.00104	0.00285	CcSEcCtD
Perhexiline—Fatigue—Melphalan—peripheral nervous system neoplasm	0.00103	0.00282	CcSEcCtD
Perhexiline—Flushing—Cisplatin—peripheral nervous system neoplasm	0.00102	0.0028	CcSEcCtD
Perhexiline—Syncope—Alitretinoin—peripheral nervous system neoplasm	0.00101	0.00276	CcSEcCtD
Perhexiline—Gastrointestinal pain—Topotecan—peripheral nervous system neoplasm	0.000998	0.00273	CcSEcCtD
Perhexiline—Gastrointestinal pain—Tretinoin—peripheral nervous system neoplasm	0.00099	0.00271	CcSEcCtD
Perhexiline—Gastrointestinal pain—Isotretinoin—peripheral nervous system neoplasm	0.00099	0.00271	CcSEcCtD
Perhexiline—Loss of consciousness—Alitretinoin—peripheral nervous system neoplasm	0.000988	0.00271	CcSEcCtD
Perhexiline—Convulsion—Alitretinoin—peripheral nervous system neoplasm	0.000974	0.00267	CcSEcCtD
Perhexiline—Urticaria—Topotecan—peripheral nervous system neoplasm	0.00097	0.00266	CcSEcCtD
Perhexiline—Abdominal pain—Topotecan—peripheral nervous system neoplasm	0.000965	0.00264	CcSEcCtD
Perhexiline—Urticaria—Isotretinoin—peripheral nervous system neoplasm	0.000962	0.00264	CcSEcCtD
Perhexiline—Urticaria—Tretinoin—peripheral nervous system neoplasm	0.000962	0.00264	CcSEcCtD
Perhexiline—Abdominal pain—Tretinoin—peripheral nervous system neoplasm	0.000957	0.00262	CcSEcCtD
Perhexiline—Abdominal pain—Isotretinoin—peripheral nervous system neoplasm	0.000957	0.00262	CcSEcCtD
Perhexiline—Urticaria—Melphalan—peripheral nervous system neoplasm	0.000949	0.0026	CcSEcCtD
Perhexiline—Anorexia—Dactinomycin—peripheral nervous system neoplasm	0.000943	0.00258	CcSEcCtD
Perhexiline—Convulsion—Vincristine—peripheral nervous system neoplasm	0.000939	0.00257	CcSEcCtD
Perhexiline—Flushing—Etoposide—peripheral nervous system neoplasm	0.000936	0.00256	CcSEcCtD
Perhexiline—Shock—Alitretinoin—peripheral nervous system neoplasm	0.000903	0.00247	CcSEcCtD
Perhexiline—Tremor—Cisplatin—peripheral nervous system neoplasm	0.000897	0.00246	CcSEcCtD
Perhexiline—Hyperhidrosis—Alitretinoin—peripheral nervous system neoplasm	0.000887	0.00243	CcSEcCtD
Perhexiline—Asthenia—Topotecan—peripheral nervous system neoplasm	0.000876	0.0024	CcSEcCtD
Perhexiline—Anorexia—Alitretinoin—peripheral nervous system neoplasm	0.000875	0.0024	CcSEcCtD
Perhexiline—Asthenia—Tretinoin—peripheral nervous system neoplasm	0.000869	0.00238	CcSEcCtD
Perhexiline—Asthenia—Isotretinoin—peripheral nervous system neoplasm	0.000869	0.00238	CcSEcCtD
Perhexiline—Decreased appetite—Dactinomycin—peripheral nervous system neoplasm	0.00086	0.00236	CcSEcCtD
Perhexiline—Asthenia—Melphalan—peripheral nervous system neoplasm	0.000857	0.00235	CcSEcCtD
Perhexiline—Hyperhidrosis—Vincristine—peripheral nervous system neoplasm	0.000855	0.00234	CcSEcCtD
Perhexiline—Fatigue—Dactinomycin—peripheral nervous system neoplasm	0.000853	0.00234	CcSEcCtD
Perhexiline—Anorexia—Vincristine—peripheral nervous system neoplasm	0.000843	0.00231	CcSEcCtD
Perhexiline—Hypoglycaemia—Epirubicin—peripheral nervous system neoplasm	0.000837	0.00229	CcSEcCtD
Perhexiline—Convulsion—Cisplatin—peripheral nervous system neoplasm	0.00083	0.00227	CcSEcCtD
Perhexiline—Insomnia—Alitretinoin—peripheral nervous system neoplasm	0.00083	0.00227	CcSEcCtD
Perhexiline—Paraesthesia—Alitretinoin—peripheral nervous system neoplasm	0.000824	0.00226	CcSEcCtD
Perhexiline—Diplopia—Epirubicin—peripheral nervous system neoplasm	0.000817	0.00224	CcSEcCtD
Perhexiline—Gastrointestinal pain—Dactinomycin—peripheral nervous system neoplasm	0.000809	0.00222	CcSEcCtD
Perhexiline—Dizziness—Topotecan—peripheral nervous system neoplasm	0.000807	0.00221	CcSEcCtD
Perhexiline—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.000801	0.00219	CcSEcCtD
Perhexiline—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.000801	0.00219	CcSEcCtD
Perhexiline—Insomnia—Vincristine—peripheral nervous system neoplasm	0.0008	0.00219	CcSEcCtD
Perhexiline—Decreased appetite—Alitretinoin—peripheral nervous system neoplasm	0.000798	0.00219	CcSEcCtD
Perhexiline—Paraesthesia—Vincristine—peripheral nervous system neoplasm	0.000794	0.00218	CcSEcCtD
Perhexiline—Fatigue—Alitretinoin—peripheral nervous system neoplasm	0.000791	0.00217	CcSEcCtD
Perhexiline—Abdominal pain—Dactinomycin—peripheral nervous system neoplasm	0.000782	0.00214	CcSEcCtD
Perhexiline—Vomiting—Topotecan—peripheral nervous system neoplasm	0.000776	0.00213	CcSEcCtD
Perhexiline—Hypoglycaemia—Doxorubicin—peripheral nervous system neoplasm	0.000774	0.00212	CcSEcCtD
Perhexiline—Loss of consciousness—Etoposide—peripheral nervous system neoplasm	0.000771	0.00211	CcSEcCtD
Perhexiline—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.00077	0.00211	CcSEcCtD
Perhexiline—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.00077	0.00211	CcSEcCtD
Perhexiline—Rash—Topotecan—peripheral nervous system neoplasm	0.00077	0.00211	CcSEcCtD
Perhexiline—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.000769	0.00211	CcSEcCtD
Perhexiline—Decreased appetite—Vincristine—peripheral nervous system neoplasm	0.000769	0.00211	CcSEcCtD
Perhexiline—Ataxia—Epirubicin—peripheral nervous system neoplasm	0.000768	0.0021	CcSEcCtD
Perhexiline—Headache—Topotecan—peripheral nervous system neoplasm	0.000765	0.00209	CcSEcCtD
Perhexiline—Rash—Tretinoin—peripheral nervous system neoplasm	0.000763	0.00209	CcSEcCtD
Perhexiline—Rash—Isotretinoin—peripheral nervous system neoplasm	0.000763	0.00209	CcSEcCtD
Perhexiline—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.000763	0.00209	CcSEcCtD
Perhexiline—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.000763	0.00209	CcSEcCtD
Perhexiline—Fatigue—Vincristine—peripheral nervous system neoplasm	0.000762	0.00209	CcSEcCtD
Perhexiline—Convulsion—Etoposide—peripheral nervous system neoplasm	0.00076	0.00208	CcSEcCtD
Perhexiline—Vomiting—Melphalan—peripheral nervous system neoplasm	0.00076	0.00208	CcSEcCtD
Perhexiline—Headache—Tretinoin—peripheral nervous system neoplasm	0.000758	0.00208	CcSEcCtD
Perhexiline—Headache—Isotretinoin—peripheral nervous system neoplasm	0.000758	0.00208	CcSEcCtD
Perhexiline—Diplopia—Doxorubicin—peripheral nervous system neoplasm	0.000756	0.00207	CcSEcCtD
Perhexiline—Hyperhidrosis—Cisplatin—peripheral nervous system neoplasm	0.000756	0.00207	CcSEcCtD
Perhexiline—Rash—Melphalan—peripheral nervous system neoplasm	0.000753	0.00206	CcSEcCtD
Perhexiline—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.000753	0.00206	CcSEcCtD
Perhexiline—Gastrointestinal pain—Alitretinoin—peripheral nervous system neoplasm	0.00075	0.00206	CcSEcCtD
Perhexiline—Anorexia—Cisplatin—peripheral nervous system neoplasm	0.000745	0.00204	CcSEcCtD
Perhexiline—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.000729	0.002	CcSEcCtD
Perhexiline—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	0.000725	0.00199	CcSEcCtD
Perhexiline—Nausea—Topotecan—peripheral nervous system neoplasm	0.000725	0.00199	CcSEcCtD
Perhexiline—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	0.000723	0.00198	CcSEcCtD
Perhexiline—Muscular weakness—Epirubicin—peripheral nervous system neoplasm	0.00072	0.00197	CcSEcCtD
Perhexiline—Nausea—Tretinoin—peripheral nervous system neoplasm	0.000719	0.00197	CcSEcCtD
Perhexiline—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.000719	0.00197	CcSEcCtD
Perhexiline—Ataxia—Doxorubicin—peripheral nervous system neoplasm	0.000711	0.00195	CcSEcCtD
Perhexiline—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.00071	0.00195	CcSEcCtD
Perhexiline—Nausea—Melphalan—peripheral nervous system neoplasm	0.00071	0.00194	CcSEcCtD
Perhexiline—Paraesthesia—Cisplatin—peripheral nervous system neoplasm	0.000702	0.00192	CcSEcCtD
Perhexiline—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.000699	0.00191	CcSEcCtD
Perhexiline—Hyperhidrosis—Etoposide—peripheral nervous system neoplasm	0.000692	0.0019	CcSEcCtD
Perhexiline—Anorexia—Etoposide—peripheral nervous system neoplasm	0.000683	0.00187	CcSEcCtD
Perhexiline—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	0.00068	0.00186	CcSEcCtD
Perhexiline—Muscular weakness—Doxorubicin—peripheral nervous system neoplasm	0.000667	0.00183	CcSEcCtD
Perhexiline—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.000658	0.0018	CcSEcCtD
Perhexiline—Paraesthesia—Etoposide—peripheral nervous system neoplasm	0.000643	0.00176	CcSEcCtD
Perhexiline—Weight decreased—Epirubicin—peripheral nervous system neoplasm	0.000639	0.00175	CcSEcCtD
Perhexiline—Asthenia—Vincristine—peripheral nervous system neoplasm	0.000634	0.00174	CcSEcCtD
Perhexiline—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000629	0.00172	CcSEcCtD
Perhexiline—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000624	0.00171	CcSEcCtD
Perhexiline—Decreased appetite—Etoposide—peripheral nervous system neoplasm	0.000623	0.00171	CcSEcCtD
Perhexiline—Fatigue—Etoposide—peripheral nervous system neoplasm	0.000617	0.00169	CcSEcCtD
Perhexiline—Neuropathy peripheral—Epirubicin—peripheral nervous system neoplasm	0.000617	0.00169	CcSEcCtD
Perhexiline—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000607	0.00166	CcSEcCtD
Perhexiline—Sweating—Epirubicin—peripheral nervous system neoplasm	0.000603	0.00165	CcSEcCtD
Perhexiline—Weight decreased—Doxorubicin—peripheral nervous system neoplasm	0.000591	0.00162	CcSEcCtD
Perhexiline—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000588	0.00161	CcSEcCtD
Perhexiline—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.000586	0.0016	CcSEcCtD
Perhexiline—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000585	0.0016	CcSEcCtD
Perhexiline—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000583	0.0016	CcSEcCtD
Perhexiline—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000579	0.00158	CcSEcCtD
Perhexiline—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000578	0.00158	CcSEcCtD
Perhexiline—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000575	0.00157	CcSEcCtD
Perhexiline—Neuropathy peripheral—Doxorubicin—peripheral nervous system neoplasm	0.000571	0.00156	CcSEcCtD
Perhexiline—Urticaria—Etoposide—peripheral nervous system neoplasm	0.000569	0.00156	CcSEcCtD
Perhexiline—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.000566	0.00155	CcSEcCtD
Perhexiline—Hepatitis—Epirubicin—peripheral nervous system neoplasm	0.000565	0.00155	CcSEcCtD
Perhexiline—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000562	0.00154	CcSEcCtD
Perhexiline—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000561	0.00154	CcSEcCtD
Perhexiline—Sweating—Doxorubicin—peripheral nervous system neoplasm	0.000558	0.00153	CcSEcCtD
Perhexiline—Rash—Vincristine—peripheral nervous system neoplasm	0.000557	0.00153	CcSEcCtD
Perhexiline—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000557	0.00153	CcSEcCtD
Perhexiline—Headache—Vincristine—peripheral nervous system neoplasm	0.000554	0.00152	CcSEcCtD
Perhexiline—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000545	0.00149	CcSEcCtD
Perhexiline—Nausea—Vincristine—peripheral nervous system neoplasm	0.000525	0.00144	CcSEcCtD
Perhexiline—Flushing—Epirubicin—peripheral nervous system neoplasm	0.000524	0.00144	CcSEcCtD
Perhexiline—Hepatitis—Doxorubicin—peripheral nervous system neoplasm	0.000523	0.00143	CcSEcCtD
Perhexiline—Asthenia—Etoposide—peripheral nervous system neoplasm	0.000514	0.00141	CcSEcCtD
Perhexiline—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000497	0.00136	CcSEcCtD
Perhexiline—Rash—Cisplatin—peripheral nervous system neoplasm	0.000493	0.00135	CcSEcCtD
Perhexiline—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000492	0.00135	CcSEcCtD
Perhexiline—Flushing—Doxorubicin—peripheral nervous system neoplasm	0.000485	0.00133	CcSEcCtD
Perhexiline—Tension—Epirubicin—peripheral nervous system neoplasm	0.000483	0.00132	CcSEcCtD
Perhexiline—Nervousness—Epirubicin—peripheral nervous system neoplasm	0.000478	0.00131	CcSEcCtD
Perhexiline—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000474	0.0013	CcSEcCtD
Perhexiline—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000464	0.00127	CcSEcCtD
Perhexiline—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000455	0.00125	CcSEcCtD
Perhexiline—Rash—Etoposide—peripheral nervous system neoplasm	0.000452	0.00124	CcSEcCtD
Perhexiline—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000451	0.00124	CcSEcCtD
Perhexiline—Headache—Etoposide—peripheral nervous system neoplasm	0.000449	0.00123	CcSEcCtD
Perhexiline—Tension—Doxorubicin—peripheral nervous system neoplasm	0.000447	0.00122	CcSEcCtD
Perhexiline—Nervousness—Doxorubicin—peripheral nervous system neoplasm	0.000442	0.00121	CcSEcCtD
Perhexiline—Syncope—Epirubicin—peripheral nervous system neoplasm	0.000441	0.00121	CcSEcCtD
Perhexiline—Loss of consciousness—Epirubicin—peripheral nervous system neoplasm	0.000432	0.00118	CcSEcCtD
Perhexiline—Convulsion—Epirubicin—peripheral nervous system neoplasm	0.000426	0.00117	CcSEcCtD
Perhexiline—Nausea—Etoposide—peripheral nervous system neoplasm	0.000425	0.00117	CcSEcCtD
Perhexiline—Syncope—Doxorubicin—peripheral nervous system neoplasm	0.000408	0.00112	CcSEcCtD
Perhexiline—Loss of consciousness—Doxorubicin—peripheral nervous system neoplasm	0.0004	0.0011	CcSEcCtD
Perhexiline—Shock—Epirubicin—peripheral nervous system neoplasm	0.000395	0.00108	CcSEcCtD
Perhexiline—Convulsion—Doxorubicin—peripheral nervous system neoplasm	0.000394	0.00108	CcSEcCtD
Perhexiline—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	0.000388	0.00106	CcSEcCtD
Perhexiline—Anorexia—Epirubicin—peripheral nervous system neoplasm	0.000383	0.00105	CcSEcCtD
Perhexiline—Shock—Doxorubicin—peripheral nervous system neoplasm	0.000365	0.001	CcSEcCtD
Perhexiline—Insomnia—Epirubicin—peripheral nervous system neoplasm	0.000363	0.000995	CcSEcCtD
Perhexiline—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	0.00036	0.000988	CcSEcCtD
Perhexiline—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	0.000359	0.000984	CcSEcCtD
Perhexiline—Anorexia—Doxorubicin—peripheral nervous system neoplasm	0.000354	0.00097	CcSEcCtD
Perhexiline—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	0.000349	0.000956	CcSEcCtD
Perhexiline—Fatigue—Epirubicin—peripheral nervous system neoplasm	0.000346	0.000948	CcSEcCtD
Perhexiline—Insomnia—Doxorubicin—peripheral nervous system neoplasm	0.000336	0.000921	CcSEcCtD
Perhexiline—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000334	0.000914	CcSEcCtD
Perhexiline—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	0.000328	0.000899	CcSEcCtD
Perhexiline—CPT1A—FOXA2 and FOXA3 transcription factor networks—NF1—peripheral nervous system neoplasm	0.000327	0.0989	CbGpPWpGaD
Perhexiline—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	0.000323	0.000885	CcSEcCtD
Perhexiline—Fatigue—Doxorubicin—peripheral nervous system neoplasm	0.00032	0.000877	CcSEcCtD
Perhexiline—Urticaria—Epirubicin—peripheral nervous system neoplasm	0.000319	0.000874	CcSEcCtD
Perhexiline—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	0.000317	0.00087	CcSEcCtD
Perhexiline—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	0.000304	0.000832	CcSEcCtD
Perhexiline—CPT1A—SIDS Susceptibility Pathways—PHOX2B—peripheral nervous system neoplasm	0.000298	0.0902	CbGpPWpGaD
Perhexiline—Urticaria—Doxorubicin—peripheral nervous system neoplasm	0.000295	0.000809	CcSEcCtD
Perhexiline—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	0.000294	0.000805	CcSEcCtD
Perhexiline—CPT2—Fatty acid, triacylglycerol, and ketone body metabolism—HSD17B12—peripheral nervous system neoplasm	0.000291	0.088	CbGpPWpGaD
Perhexiline—Asthenia—Epirubicin—peripheral nervous system neoplasm	0.000288	0.000789	CcSEcCtD
Perhexiline—Asthenia—Doxorubicin—peripheral nervous system neoplasm	0.000267	0.00073	CcSEcCtD
Perhexiline—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.000265	0.000727	CcSEcCtD
Perhexiline—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.000255	0.000699	CcSEcCtD
Perhexiline—Rash—Epirubicin—peripheral nervous system neoplasm	0.000253	0.000694	CcSEcCtD
Perhexiline—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.000253	0.000693	CcSEcCtD
Perhexiline—Headache—Epirubicin—peripheral nervous system neoplasm	0.000252	0.000689	CcSEcCtD
Perhexiline—Dizziness—Doxorubicin—peripheral nervous system neoplasm	0.000246	0.000673	CcSEcCtD
Perhexiline—Nausea—Epirubicin—peripheral nervous system neoplasm	0.000238	0.000653	CcSEcCtD
Perhexiline—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.000236	0.000647	CcSEcCtD
Perhexiline—Rash—Doxorubicin—peripheral nervous system neoplasm	0.000234	0.000642	CcSEcCtD
Perhexiline—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.000234	0.000641	CcSEcCtD
Perhexiline—Headache—Doxorubicin—peripheral nervous system neoplasm	0.000233	0.000638	CcSEcCtD
Perhexiline—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.000221	0.000605	CcSEcCtD
Perhexiline—CPT1A—Fatty acid, triacylglycerol, and ketone body metabolism—HSD17B12—peripheral nervous system neoplasm	0.000202	0.061	CbGpPWpGaD
Perhexiline—CPT2—PPAR Alpha Pathway—MYC—peripheral nervous system neoplasm	0.000151	0.0457	CbGpPWpGaD
Perhexiline—CPT2—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	0.000116	0.035	CbGpPWpGaD
Perhexiline—CYP2D6—Codeine and Morphine Metabolism—ABCB1—peripheral nervous system neoplasm	0.000112	0.0337	CbGpPWpGaD
Perhexiline—CPT1A—PPAR Alpha Pathway—MYC—peripheral nervous system neoplasm	0.000105	0.0317	CbGpPWpGaD
Perhexiline—CPT1A—SIDS Susceptibility Pathways—NTRK2—peripheral nervous system neoplasm	8.58e-05	0.026	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	8.03e-05	0.0243	CbGpPWpGaD
Perhexiline—CPT1A—SIDS Susceptibility Pathways—TH—peripheral nervous system neoplasm	7.86e-05	0.0238	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—PPIP5K2—peripheral nervous system neoplasm	7.63e-05	0.0231	CbGpPWpGaD
Perhexiline—CYP3A4—Codeine and Morphine Metabolism—ABCB1—peripheral nervous system neoplasm	7.29e-05	0.0221	CbGpPWpGaD
Perhexiline—CPT1A—Circadian rythm related genes—TH—peripheral nervous system neoplasm	6.42e-05	0.0194	CbGpPWpGaD
Perhexiline—CPT1A—SIDS Susceptibility Pathways—BDNF—peripheral nervous system neoplasm	6.41e-05	0.0194	CbGpPWpGaD
Perhexiline—CYP3A4—Irinotecan Pathway—BCHE—peripheral nervous system neoplasm	6.19e-05	0.0187	CbGpPWpGaD
Perhexiline—CPT1A—Circadian rythm related genes—NTRK1—peripheral nervous system neoplasm	5.71e-05	0.0173	CbGpPWpGaD
Perhexiline—CYP2B6—Constitutive Androstane Receptor Pathway—ABCB1—peripheral nervous system neoplasm	5.29e-05	0.016	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—PPIP5K2—peripheral nervous system neoplasm	5.29e-05	0.016	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—HSD17B12—peripheral nervous system neoplasm	5.16e-05	0.0156	CbGpPWpGaD
Perhexiline—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—peripheral nervous system neoplasm	5.04e-05	0.0153	CbGpPWpGaD
Perhexiline—CPT1A—FOXA2 and FOXA3 transcription factor networks—AKT1—peripheral nervous system neoplasm	4.77e-05	0.0144	CbGpPWpGaD
Perhexiline—CPT2—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	4.29e-05	0.013	CbGpPWpGaD
Perhexiline—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—peripheral nervous system neoplasm	3.99e-05	0.0121	CbGpPWpGaD
Perhexiline—CPT1A—AMPK Signaling—TP53—peripheral nervous system neoplasm	3.94e-05	0.0119	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—GNS—peripheral nervous system neoplasm	3.73e-05	0.0113	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—HSD17B12—peripheral nervous system neoplasm	3.57e-05	0.0108	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—NME1—peripheral nervous system neoplasm	3.57e-05	0.0108	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—COX2—peripheral nervous system neoplasm	3.44e-05	0.0104	CbGpPWpGaD
Perhexiline—CPT1A—AMPK Signaling—AKT1—peripheral nervous system neoplasm	3.33e-05	0.0101	CbGpPWpGaD
Perhexiline—CPT1A—SIDS Susceptibility Pathways—CASP3—peripheral nervous system neoplasm	3.2e-05	0.00968	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	2.97e-05	0.00899	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—GNS—peripheral nervous system neoplasm	2.58e-05	0.00782	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—NME1—peripheral nervous system neoplasm	2.48e-05	0.0075	CbGpPWpGaD
Perhexiline—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—peripheral nervous system neoplasm	2.41e-05	0.00728	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—COX2—peripheral nervous system neoplasm	2.38e-05	0.00721	CbGpPWpGaD
Perhexiline—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—peripheral nervous system neoplasm	2.29e-05	0.00693	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—ENO2—peripheral nervous system neoplasm	2.26e-05	0.00683	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—BCHE—peripheral nervous system neoplasm	1.91e-05	0.00577	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.82e-05	0.00551	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—TH—peripheral nervous system neoplasm	1.79e-05	0.00543	CbGpPWpGaD
Perhexiline—CPT1A—Circadian rythm related genes—TP53—peripheral nervous system neoplasm	1.68e-05	0.00507	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—ENO2—peripheral nervous system neoplasm	1.57e-05	0.00474	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—GNAS—peripheral nervous system neoplasm	1.46e-05	0.00443	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—ABCB1—peripheral nervous system neoplasm	1.44e-05	0.00435	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—BCHE—peripheral nervous system neoplasm	1.32e-05	0.004	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.26e-05	0.00382	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—PPIP5K2—peripheral nervous system neoplasm	1.25e-05	0.00379	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—TH—peripheral nervous system neoplasm	1.24e-05	0.00376	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—GNAS—peripheral nervous system neoplasm	1.02e-05	0.00307	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—ABCB1—peripheral nervous system neoplasm	9.96e-06	0.00301	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—PPIP5K2—peripheral nervous system neoplasm	8.7e-06	0.00263	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—HSD17B12—peripheral nervous system neoplasm	8.46e-06	0.00256	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—GNS—peripheral nervous system neoplasm	6.12e-06	0.00185	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—HSD17B12—peripheral nervous system neoplasm	5.88e-06	0.00178	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—NME1—peripheral nervous system neoplasm	5.86e-06	0.00177	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—PPIP5K2—peripheral nervous system neoplasm	5.69e-06	0.00172	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—COX2—peripheral nervous system neoplasm	5.64e-06	0.00171	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—GNS—peripheral nervous system neoplasm	4.25e-06	0.00129	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—NME1—peripheral nervous system neoplasm	4.07e-06	0.00123	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—AKT1—peripheral nervous system neoplasm	3.95e-06	0.0012	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—COX2—peripheral nervous system neoplasm	3.92e-06	0.00119	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—HSD17B12—peripheral nervous system neoplasm	3.84e-06	0.00116	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—ENO2—peripheral nervous system neoplasm	3.7e-06	0.00112	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—BCHE—peripheral nervous system neoplasm	3.13e-06	0.000947	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—SLC2A1—peripheral nervous system neoplasm	2.99e-06	0.000903	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—TH—peripheral nervous system neoplasm	2.94e-06	0.00089	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—GNS—peripheral nervous system neoplasm	2.78e-06	0.000841	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—AKT1—peripheral nervous system neoplasm	2.74e-06	0.000829	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—NME1—peripheral nervous system neoplasm	2.66e-06	0.000806	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—ENO2—peripheral nervous system neoplasm	2.58e-06	0.000779	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—COX2—peripheral nervous system neoplasm	2.56e-06	0.000776	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—GNAS—peripheral nervous system neoplasm	2.4e-06	0.000727	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—ABCB1—peripheral nervous system neoplasm	2.36e-06	0.000713	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—BCHE—peripheral nervous system neoplasm	2.18e-06	0.000658	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—SLC2A1—peripheral nervous system neoplasm	2.08e-06	0.000628	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—TH—peripheral nervous system neoplasm	2.05e-06	0.000619	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—ENO2—peripheral nervous system neoplasm	1.68e-06	0.000509	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—GNAS—peripheral nervous system neoplasm	1.67e-06	0.000505	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—ABCB1—peripheral nervous system neoplasm	1.64e-06	0.000496	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—BCHE—peripheral nervous system neoplasm	1.42e-06	0.00043	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.36e-06	0.000411	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—TH—peripheral nervous system neoplasm	1.34e-06	0.000405	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—GNAS—peripheral nervous system neoplasm	1.09e-06	0.00033	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—ABCB1—peripheral nervous system neoplasm	1.07e-06	0.000324	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—AKT1—peripheral nervous system neoplasm	6.49e-07	0.000196	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—AKT1—peripheral nervous system neoplasm	4.51e-07	0.000136	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—AKT1—peripheral nervous system neoplasm	2.95e-07	8.92e-05	CbGpPWpGaD
